Cyclopharm Limited
Cyclopharm Limited
Your view on CYC.AX
Overview
What the company does, where it operates, and who runs it.
About Cyclopharm Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- James S. McBrayer BSPharm
- Headquarters
- 1 The Crescent, Kingsgrove, NSW, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- James S. McBrayer BSPharm
- Headquarters
- 1 The Crescent, Kingsgrove, NSW, AU
Cyclopharm Limited is an international enterprise specializing in the production and global distribution of medical devices and radiopharmaceuticals, with operations spanning Asia Pacific, Europe, Canada, and other regions. The company's business activities are structured into two principal divisions: Technegas and Molecular Imaging.
Through its Technegas segment, Cyclopharm supplies diagnostic apparatus and accompanying consumables critical for clinicians in the identification of pulmonary embolisms, alongside distributing third-party offerings to the broader diagnostic imaging sector.
Conversely, the Molecular Imaging division provides advanced radiopharmaceutical agents essential for medical practitioners diagnosing conditions such as cancer, various neurological disorders, and cardiac diseases. Cyclopharm primarily serves nuclear medicine departments.
Established in 1986, the company's corporate headquarters are located in Kingsgrove, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cyclopharm Limited. Starting points for Cyclopharm Limited: EPS -AUD 0.15, beta 0.57 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cyclopharm Limited. Cyclopharm Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cyclopharm Limited. Trailing twelve-month EPS for Cyclopharm Limited stands at -AUD 0.15. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrDec 2026 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|
| Avg. estimate | AUD 0.00 | −AUD 0.14 | −AUD 0.09 |
| Low estimate | AUD 0.00 | −AUD 0.14 | −AUD 0.09 |
| High estimate | AUD 0.00 | −AUD 0.14 | −AUD 0.09 |
| No. of analysts | 0 | 1 | 1 |
| Year-ago EPS | −AUD 0.05 | −AUD 0.161 | — |
| Growth | +100.0% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|
| Avg. estimate | AUD 19.70M | AUD 37.20M | AUD 47.20M |
| Low estimate | AUD 19.70M | AUD 37.20M | AUD 47.20M |
| High estimate | AUD 19.70M | AUD 37.20M | AUD 47.20M |
| No. of analysts | 1 | 1 | 1 |
| Year-ago revenue | AUD 14.37M | AUD 32.33M | — |
| Growth | +37.1% | +15.1% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cyclopharm Limited. Cyclopharm Limited has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ATX.AXAmplia Therapeutics Limited | Healthcare | Biotechnology | — | ||
| BMT.AXBeamtree Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| CMP.AXCompumedics Limited | Healthcare | Medical - Devices | — | ||
| CSX.AXCleanSpace Holdings Limited | Healthcare | Medical - Devices | — | ||
| CYP.AXCynata Therapeutics Limited | Healthcare | Biotechnology | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IPD.AXImpediMed Limited | Healthcare | Medical - Devices | — | ||
| M7T.AXMach7 Technologies Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBL.AXControl Bionics Limited | Healthcare | ASX | — | ||
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cyclopharm Limited. Coverage tracks Cyclopharm Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cyclopharm Limited.